NCT04160780

Brief Summary

Severe maxillary atrophy occurs after extraction of teeth in poster maxilla due to dimensional changes occur after removal; besides, sinus membrane pneumatization causes alveolar bone resorption, different classification for remaining alveolar bone in the posterior maxilla were done. In this study, the ABC sinus classification was followed in case selection. A sinus augmentation is done with several techniques. Sinus membrane elevation is done with two different approaches, either the crestal approach or lateral window approach. Using biofiller material for sinus membrane elevation has been tried by many researchers, using a bone graft, platelet concentrates preparation, collagen membranes, tenting screws, or with implant tenting. In this study, sinus augmentation was performed using a lateral window approach using L-PRF as sole biofiller material in one group, xenograft as only biofiller material in the second group and mixed xenograft with L-PRF in the third group. Histomorphometric analysis was done from the core biopsy after three months of augmentation, and implant placement was done. After three months, prosthetic parts were placed. The results of this study show that the augmentation of the sinus using L-PRF mixed with bone graft is showing the best results followed by L-PRF only, and the least was xenograft. From this point of discussion, it can be considered that using L-PRF as sole biofiller material in sinus augmentation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 13, 2019

Completed
Last Updated

December 5, 2019

Status Verified

December 1, 2019

Enrollment Period

2.9 years

First QC Date

September 8, 2019

Last Update Submit

December 4, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • histomorphometric analysis

    After three months from sinus augmentation, a second surgery will be done for implant placement; during this procedure, a bone core biopsy will be harvested. The biopsy will be stained with mason stain for histomorphometric analysis. The aim is to measure the newly formed bone for three months.

    3 months

Study Arms (3)

L-PRF as sole graft material

EXPERIMENTAL

lateral sinus augmentation using L-PRF as sole graft material

Procedure: L-PRF

xenograft as sole graft material

EXPERIMENTAL

lateral sinus augmentation using xenograft as sole graft material

Procedure: xenograft

Xenograft mixed with L-PRF as graft material

EXPERIMENTAL

lateral sinus augmentation using L-PRF mixed with xenograft as graft material

Procedure: L-PRF mixed with xenograft

Interventions

L-PRFPROCEDURE

sinus augmentation using L-PRf as sole graft material

L-PRF as sole graft material

sinus augmentation using L-PRF mixed with xenograft as sole graft material

Xenograft mixed with L-PRF as graft material
xenograftPROCEDURE

sinus augmentation using xenograft as sole graft material

xenograft as sole graft material

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult patients.
  • Both sex, males and females.
  • Age from 24 - 49 years old.
  • All patients were free from any systemic diseases as evidenced by Burkett's oral medicine health history questionnaire.
  • Extraction done at posterior maxilla involved with the maxillary sinus.
  • Remaining alveolar bone ≤ 5mm vertically and ≥ 4mm horizontally and from 1.5 mm to 3.5 mm vertically.
  • Gingival biotype 1-2mm thickness.
  • Patient has no previous surgery in Maxillary antrum.

You may not qualify if:

  • Smokers.
  • Pregnant and breast-feeding females.
  • Mentally retarded Patients.
  • Presence of hematologic disease.
  • Previous radiation, chemotherapy, or immunosuppressive treatments.
  • Diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy.
  • Patient with history of chronic sinus pathosis
  • Anticoagulant drugs, Endocarditis risk factors, renal and hepatic failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Maxillary Diseases

Interventions

Transplantation, Heterologous

Condition Hierarchy (Ancestors)

Jaw DiseasesMusculoskeletal DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

September 8, 2019

First Posted

November 13, 2019

Study Start

March 26, 2016

Primary Completion

March 1, 2019

Study Completion

April 1, 2019

Last Updated

December 5, 2019

Record last verified: 2019-12